What is ISoP?
The International Society of Pharmacovigilance (ISoP) is an international non-profit scientific organisation, which aims to foster Pharmacovigilance both scientifically and educationally, and enhance all aspects of the safe and proper use of medicines, in all countries. more…
Join ISoP Today
Mira Harrison, president of the International Society of Pharmacovigilance talks about the benefits and fees of becoming a member.
COVID-19 Information
ISoP Seminar
ISoP Boston Seminar 2021
06-07 December 2021
Intelligent Automation in Pharmacovigilance.
REGISTER NOW
ISoP Training
ISoP-DSRU Mid-Year Training
10-11 May 2022
Webinar - Beyond spontaneous reporting: integrating data from multiple sources to ensure medicines safety
REGISTER INTEREST
ISoP 2022
ISoP Annual Meeting
20-23 September 2022
A new Era of Pharmacovigilance: challenges and opportunities
READ MORE
PSD 2021
ISoP 2021
Chapter and SIG Activities
For more information click below.
What’s New
Welcome to the South Asia Chapter of ISoP!
FDA June 2021 Guidance on IND Reporting.
ISoP infographic ‘COVID-19 Vaccine Safety’.
Webinars section for Members.
New ISoP membership fees 2021 and Membership Categories.
ISoP editorials in Drug Safety journal.
CIOMS Establishes Annual Award for Medical Students.
Updated ISoP Privacy Policy.
ISoP Latest
ISoP
@ISoPonline
ISoP Chapters are locally-established organizations that actively address the needs arising from the whole range of… https://t.co/x075TBya6g
Dec 1
ISoP
@ISoPonline
Becoming an #ISoPMember: Select 'apply now' on: https://t.co/Cd2JOFq1dV… , complete the application form. If your a… https://t.co/b1vl98ySyy
Nov 29
President of ISoP
I am honoured and delighted to have been elected as President of ISoP – as announced on 28th October 2019 at our Annual General Meeting in Bogota – and am especially proud to be the first woman to ever hold this role in our professional society.
Mira Harrison‐Woolrych
President – International Society of Pharmacovigilance
Drug Safety
ISoP Official Journal
Drug Safety is the premier international journal covering the disciplines of pharmacovigilance, pharmacoepidemiology, benefit-risk assessment and risk management.